NAT10 drives hepatocellular carcinoma progression through SQLE-mediated cholesterol biosynthesis and is targetable by remodelin.
NAT10 通过 SQLE 介导的胆固醇生物合成驱动肝细胞癌的进展,并且是重塑素的靶点。
期刊:iScience
影响因子:4.1
doi:10.1016/j.isci.2025.114488
Wang Yumeng, Yang Xun, Dong Yihong, Yang Xinxin, Hou Yunjing, Fu Qiang, Yan Jun, Du Yulu, Zhang Qingxin, Zhou Yunfei, Wu Aodi, Chang Shuyuan, Xu Jianwen, Zhang Chunhui, Hu Xiaoyang, Meng Hongxue, Sun Wei, Liu Dabin